PAVM
PAVmed Inc.
NASDAQ · Healthcare · Medical - Devices · US
$5.28
+3.73%Year over year
Reported trailing growth
- Revenue
- -89.0%
- EBITDA
- —
- EBIT
- +0.8%
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +217.0%
- EBITDA
- +18.2%
- EPS
- +86.9%
Three-year CAGR
- Revenue
- -42.7%
- EBITDA
- —
- EBIT
- +51.0%
- Net income
- -99.0%
- EPS
- —
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026